BFEC
QCOR

Benjamin F. Edwards & Company’s QUESTCOR PHARMA INC QCOR Stock Holding History

Benjamin F. Edwards & Company’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-950
Closed -$62K – 973
2014
Q1 		$62K Buy
+950
New +$60.7K 0.02% 428

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Benjamin F. Edwards & Company's QCOR Position: Q2 2014 in Review

Benjamin F. Edwards & Company sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 950 shares — an estimated $62K sold.

Benjamin F. Edwards & Company first reported a position in QCOR in Q1 2014 and held it in 1 quarter. The position peaked at $62K in Q1 2014. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Benjamin F. Edwards & Company reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 950 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $62K.
  • Benjamin F. Edwards & Company first reported a position in QUESTCOR PHARMA INC in Q1 2014 and held it in 1 quarter.
  • Benjamin F. Edwards & Company's QUESTCOR PHARMA INC position peaked at $62K in Q1 2014.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2014, filed 21 Jul 2014.